Condensed Statements of Cash Flows (USD $)	6 Months Ended		80 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2012
Operating Activities:
Net loss	$ (11,416,372)	$ (94,823,522)	$ (194,423,308)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	3,081,163	4,773,758	21,428,187
Stock based compensation	551,688	1,101,292	12,439,065
Common stock issued for services	0	58,950	58,950
Realized loss on forward contracts	0	(63,915)	1,430,766
Foreign currency transaction loss (gain)	5,365	(263,767)	(590,433)
Amortization of financing costs and discounts	0	0	998,565
Impairment loss	0	78,000,000	79,769,480
Contract cancellation loss	0	0	590,774
Changes in operating assets and liabilities:
Accounts receivable	214,204	(158,660)	(127,883)
Inventories	160,388	(1,505,117)	(2,308,735)
Prepaid expenses and other current assets	(147,762)	118,353	(534,386)
Accounts payable	(173,387)	(417,307)	485,447
Related party payable	0	(51,889)	0
Accrued expenses	(115,095)	848,761	1,004,409
Deferred revenue	0	(227,695)	0
Warranty reserve	0	5,803	26,660
Net cash used in operating activities	(7,839,808)	(12,604,955)	(79,752,442)
Investing Activities:
Purchases of available-for-sale-securities	(638,572)	(21,202,034)	(907,118,827)
Maturities and sales of available-for-sale securities	13,253,650	23,798,740	907,118,828
Purchase of property, plant and equipment	(4,260,552)	(3,687,814)	(132,815,348)
Restricted cash for manufacturing equipment	958,391	(3,167,040)	(468,662)
Patent activity costs	(46,636)	(18,318)	(358,712)
Net cash provided by (used in) investing activities	9,266,281	(4,276,466)	(133,642,721)
Financing Activities:
Proceeds from bridge loan financing	0	0	1,600,000
Repayment of bridge loan financing	0	0	(1,600,000)
Payment of debt financing costs	0	0	(273,565)
Payment of equity offering costs	0	0	(10,302,040)
Proceeds from debt	0	0	7,700,000
Repayment of debt	(521,989)	(464,218)	(2,058,860)
Proceeds from shareholder under Section 16(b)	0	0	148,109
Proceeds from issuance of stock and warrants	1,236,663	5,600	231,669,679
Redemption of Class A warrants	0	0	(48,128)
Net cash provided by (used in) financing activities	714,674	(458,618)	226,835,195
Net change in cash and cash equivalents	2,141,147	(17,340,039)	13,440,032
Cash and cash equivalents at beginning of period	11,298,885	27,303,217	0
Cash and cash equivalents at end of period	13,440,032	9,963,178	13,440,032
Non-Cash Transactions:
ITN initial contribution of assets for equity	0	0	31,200
Note with ITN and related capital expenditures	$ 0	$ 0	$ 1,100,000